Insider of KEYS stock (KEYS) files Rule 144 to sell 889 shares
Rhea-AI Filing Summary
A holder of KEYS common stock has filed a notice of proposed sale under Rule 144. The filing covers 889 shares of common stock, with an aggregate market value of $183,677.69, to be sold on the NYSE through Fidelity Brokerage Services LLC, with an approximate sale date of 12/30/2025. The issuer has 171,817,127 shares of this class outstanding.
The shares to be sold were acquired from the issuer between 2021 and 2024 through a mix of restricted stock vesting and employee stock purchase plan (ESPP) transactions, paid via compensation and cash. By signing the notice, the seller represents that they do not know of any undisclosed material adverse information about the issuer’s current or prospective operations.
Positive
- None.
Negative
- None.
FAQ
What does the KEYS Rule 144 filing report?
The filing reports that a holder of KEYS common stock intends to sell 889 shares under Rule 144, using Fidelity Brokerage Services LLC to execute the sale on the NYSE around 12/30/2025.
How many KEYS shares are covered by this Rule 144 notice?
The notice covers 889 shares of KEYS common stock, with an aggregate market value of $183,677.69 as stated in the filing.
How many KEYS shares are outstanding compared with the shares to be sold?
The filing states that there are 171,817,127 shares of KEYS common stock outstanding, compared with the 889 shares that are proposed to be sold under this notice.
How were the KEYS shares being sold acquired?
The shares were acquired from the issuer between 2021 and 2024 through restricted stock vesting and employee stock purchase plan (ESPP) purchases, with consideration in the form of compensation and cash.
Which broker and exchange are involved in this KEYS Rule 144 sale?
The filing lists Fidelity Brokerage Services LLC as the broker, with the planned sale of KEYS common stock to occur on the NYSE.
What representation does the seller make in the KEYS Rule 144 notice?
By signing, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.